Osteoarthritis Market Expansion Outlook: $10.74 Billion by 2029 Forecast

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Osteoarthritis Market From 2025 To 2034?

The osteoarthritis market size has experienced significant growth in recent years. It is anticipated to increase from $6.87 billion in 2024 to $7.49 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.1%. This historical expansion can be attributed to factors such as the aging population, the obesity epidemic, advancements in imaging, and enhanced pain management techniques.

The market for osteoarthritis is anticipated to experience substantial expansion over the upcoming years. By 2029, its valuation is projected to reach $10.74 billion, exhibiting a compound annual growth rate (CAGR) of 9.4%. This anticipated growth is largely driven by factors such as non-pharmacological methods, disease-modifying osteoarthritis drugs (dmoads), tailored medical treatments, and the adoption of telehealth and remote monitoring. Significant developments projected for this period encompass regenerative therapies, the use of wearable devices, the integration of artificial intelligence in diagnostics, and various digital health tools.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp

What Are The Drivers Pushing New Developments In The Osteoarthritis Market?

The projected rise in disorders associated with obesity is expected to stimulate the expansion of the osteoarthritis market. Obesity-related problems encompass various health concerns that stem from excessive body fat. These conditions often arise from consuming more calories than expended through physical activity and exercise, along with a high intake of processed or fast food and excessive alcohol consumption. Obesity can lead to osteoarthritis by straining joints, causing inflammation, and altering hormones, which subsequently increases the load on the joints. For example, the World Obesity Atlas 2022, released by the UK-based non-profit World Obesity Federation, predicts that 1 billion people globally, including 1 in 7 men and 1 in 5 women, will be living with obesity by 2030. This figure is expected to climb to 4 billion people, or 51% of the global population, who will be living either overweight or obese by 2035. Thus, the growing prevalence of obesity-related disorders is a significant driver for the osteoarthritis market’s growth.

What Are The Major Segments Identified In The Osteoarthritis Market?

The osteoarthritismarket covered in this report is segmented –

1) By Treatment: Medication; Surgery; Therapy

2) By Diagnosis: Imaging; Joint Fluid Analysis

3) By Route Of Administration: Parenteral Route; Topical Route; Oral Route

4) By Disease Type: Knee Osteoarthritis; Spine Osteoarthritis; Foot And Ankle Osteoarthritis; Shoulder Osteoarthritis; Hand Osteoarthritis

5) By End-User: Hospitals; Medical Institutes

Subsegments:

1) By Medication: Pain Relievers; Corticosteroids; Hyaluronic Acid Injections; Disease-Modifying Osteoarthritis Drugs (DMOADs)

2) By Surgery: Joint Replacement Surgery; Arthroscopy; Osteotomy; Joint Fusion

3) By Therapy: Physical Therapy; Occupational Therapy; Weight Management Programs; Assistive Devices

What Trends Are Expected To Drive The Osteoarthritis Market?

Leading companies in the osteoarthritis market are increasingly employing a strategic partnership strategy to improve technology integration and broaden their market reach. A strategic partnership typically denotes a collaborative relationship between two or more organizations that unite their resources, expertise, and efforts to achieve shared goals or objectives. For example, in July 2024, LG Chem, a pharmaceutical company based in South Korea, entered the Chinese market by partnering with Yifan Pharmaceutical Co., Ltd., a pharmaceutical research and production company from China. This collaboration is for the introduction of Synovian injection for osteoarthritis, which offers therapeutic effects similar to traditional multi-injection formulations but requires only one administration. Key attributes of Synovian include its high molecular weight (10 million Dalton) hyaluronic acid, which boosts viscoelasticity and joint function, and its capacity to substantially reduce knee pain, confirmed by clinical phase 3 trial results. This development positions Synovian as a viable option for patients seeking convenient relief from osteoarthritis symptoms.

Which Leading Companies Dominate The Osteoarthritis Market Share?

Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics PLC, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Osteoarthritis Market?

North America was the largest region in the osteoarthritis market in 2024. The regions covered in osteoarthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Osteoarthritis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13022&type=smp

Browse Through More Reports Similar to the Global Osteoarthritis Market 2025, By The Business Research Company

Arthritis Monoclonal Antibodie Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodie-global-market-report

Psoriatic Arthritis Treatments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report

Companion Animal Arthritis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795